Skip to content

Clinical trials

Completed Hematologic Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Completed Country / region: Netherlands Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20081
20092
20121
20134
20142
20163
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Gamida Cell ltd2
Janssen-Cilag B.V.2
AbbVie1
Amgen1
Amsterdam UMC, location VUmc1
Chroma Therapeutics1
Jan-Willem C Alffenaar1
Kiadis Pharma1
Kyowa Kirin Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms19
Leukemia, Myeloid, Acute5
Neoplasms4
Multiple Myeloma3
Myelodysplastic Syndromes3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Bone Marrow Diseases1
Breast Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.